Stay updated with breaking news from Nasdaq Viri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 111,000 shares, a decrease of 42.7% from the October 15th total of 193,800 shares. Based on an average daily volume of 599,200 shares, the short-interest ratio […]
McCollum Christoferson Group LLC acquired a new stake in Virios Therapeutics, Inc. (NASDAQ:VIRI – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 30,700 shares of the company’s stock, valued at approximately $42,000. A number of other hedge funds […]
Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report) was the recipient of a significant decline in short interest in the month of September. As of September 30th, there was short interest totalling 278,500 shares, a decline of 33.4% from the September 15th total of 418,400 shares. Based on an average daily volume of 546,700 shares, […]
ATLANTA, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on...
ATLANTA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on...